内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议
添加时间:2010-08-02 原文发表:2010-08-02 人气:77
| 本文章共3187字，分2页，当前第2页，快速翻页： | ||
To ensure that the industry continues to grow, the survey observes that New Jersey needs to: (1) continue to provide economic incentives to attract and retain key personnel necessary to breakthrough science research; (2) maintain a strong academic environment for early-stage research; and (3) maintain and build the entrepreneurial spirit needed to bring breakthrough science to commercialization. About BioNJ With more than 275 member companies, BioNJ is singularly focused on the growth and prosperity of New Jersey's biotechnology cluster. Founded in 1994 by New Jersey industry CEOs, BioNJ serves as the voice of biotechnology companies located in New Jersey, seeks to advance their economic growth and development and works to encourage new and established companies from around the world to locate to New Jersey. BioNJ represents companies engaged in biopharmaceutical, biomedical, bioagricultural and bioremedial endeavors. To learn more about BioNJ, please visit www.BioNJ.org. About Ernst & Young Ernst & Young, a global leader in professional services, is committed to restoring the public's trust in professional services firms and in the quality of financial reporting. Its 103,000 people in more than 140 countries around the globe pursue the highest levels of integrity, quality, and professionalism to provide clients with solutions based on financial, transactional, and risk-management knowledge in Ernst & Young's core services of audit, tax, and corporate finance. Ernst & Young practices also provide legal services in those parts of the world where permitted. Further information about Ernst & Young and its approach to a variety of business issues can be found at www.ey.com/us/perspectives. Ernst & Young refers to all the members of the global Ernst & Young organization. E&Y has a long standing commitment to the life sciences industry serving more than 50 percent of the public life science companies; we are the largest professional services practice serving the industry. The E&Y life sciences practice includes biotech, medical device, generic pharmaceutical, and specialty pharmaceutical companies. Our size and success has allowed us to make enormous investments in research and keep our professionals current on the evolving issues and trends facing the industry today and what is most likely to affect the life sciences industry moving into the future. Industry focus means we recruit, train and reward our professionals within the context of industry specialization. We develop technologies and processes that are guided by industry consideration.
Contact: BioNJ 转载自pharmaLive |